Dermal toxicity of sulfur mustard

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 611-630

  Gerecke, Donald R ^a   Gray, Joshua P ^b   Shakarjian, Michael P ^c   Casillas, Robert P ^d  

^a RUTGERS UNIVERSITY   (United States)

^b U S COAST GUARD ACADEMY   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d BATTELLE MEMORIAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884780518     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374484-5.00041-9     Document Type: Chapter

References (213)

1. Aasted A., Darre E., Wulf H.C. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann. Plast Surg 1987, 19:3-330.
2. Amir A., Chapman S., Gozes Y., Sahar R., Allon N. Protection by extracellular glutathione against sulfur mustard induced toxicity. in vitro. Hum. Exp. Toxicol 1998, 17:60-652.
3. Amitai G., Adani R., Fishbein E., Meshulam H., Laish I., Dachir S. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. Chem. Biol. Interact 2005, 157-8:2-361.
4. Amitai G., Adani R., Fishbein E., Meshulam H., Laish I., Dachir S. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. J. Appl. Toxicol 2006, 26(1):7-81.
5. Andrew D.J., Lindsay C.D. Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by glutathione esters. Hum. Exp. Toxicol 1998, 17:95-387.
6. Arroyo C.M., Schafer R.J., Kurt E.M., Broomfield C.A., Carmichael A.J. Response of normal human keratinocytes to sulfur mustard: cytokine release. J. Appl. Toxicol 2000, 20(Suppl. 1):S63-S72.
7. Atkins K.B., Lodhi I.J., Hurley L.L., Hinshaw D.B. N-acetylcysteine and endothelial cell injury by sulfur mustard. J. Appl. Toxicol 2000, 20(Suppl. 1):S125-S128.
8. Babin M.C., Ricketts K.M., Skvorak J.P., Gazaway M., Mitcheltree L.W., Casillas R.P. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). Proceedings of the 38th Annual Meeting of the Society of Toxicology 1999, Vol. 48. Oxford University Press, New Orleans, LA, 367 pp.
9. Babin M.C., Ricketts K., Skvorak J.P., Gazaway M., Mitcheltree L.W., Casillas R.P. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol 2000, 20(Suppl. 1):S141-S144.
10. Babin M.C., Ricketts K.M., et al. A 7-day mouse model to assess protection from sulfur mustard (SM) skin injury. J. Toxicol. Cutan. Ocul. Toxicol 2003, 22(4):42-231.
11. Balali-Mood M., Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam. Clin. Pharmacol 2005, 19:297-315.
12. Balali-Mood M., Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin. Pharmacol. Toxicol 2006, 99:82-273.
13. Bartek M.J., LaBudde J.A., Maibach H.I. Skin permeability in vivo: comparison in rat, rabbit, pig and man. J. Invest. Dermatol 1972, 58:23-114.
14. Bartlett P.D., Swain C.G. Kinetics of hydrolysis and displacement reactions of b, b0-dichlorodiethyl sulfide (mustard gas) and of b-chloro-b0-hydroxydiethyl sulfide (mustard chlorohydrin). J. Am. Chem. Soc. 1949, 71:15-1406.
15. Bonadonna G., Karnofsky D.A. Protection studies with sodium thiosulfate against methyl bis (b-chloroethyl) amine hydrochloride (HN2) and its ethylenimonium derivative. Clin. Pharmacol. Ther 1965, 6:50-64.
16. Brand L.M., Skare K.L., et al. Anti-inflammatory pharmacology and mechanism of the orally active capsaicin analogs, NE-19550 and NE-28345. Agents Actions 1990, 31:40-329.
17. Braue, E.H., Hobson, S.T. (2005). Nanomaterials as active components in chemical warfare agent barrier creams. In Defense Applications of Nanomaterials, Vol. 11 (A.W. Miziolek et al., eds), pp. 153-69. Oxford University Press, New York, NY.
18. Brimfield, A.A. (2004). Sulfur mustard: searching for the primary biochemical lesion. Proceedings of the U.S. Army Medical Defense Bioscience Review, Aberdeen Proving Ground, MD, pp. 1-46.
19. Bunker C.B., Cerio R., Bull H.A., Evans J., Dowd P.M., Foreman J.C. The effect of capsaicin application on mast cells in normal human skin. Agents Actions 1991, 33:6-195.
20. Buxton K.L., Danne M.M., et al. Gene array analyses of sulfur mustard-induced inflammatory mediator response in mouse ears. Proceedings of the 40th Annual Meeting of the Society of Toxicology 2001, Vol. 60. Oxford University Press, San Francisco, CA, 617 pp.
21. Byrne M.P., Broomfield C.A., Stites W.E. Mustard gas crosslinking of proteins through preferential alkylation of cysteines. J. Protein Chem. 1996, 15:6-131.
22. Campbell E., Bevan S., Drary A. Clinical applications of capsaicin and its analogues. Capsaicin in the Study of Pain 1993, 69-255. Harcourt Brace & Co., London. J. Wood (Ed.).
23. Casbohm S.L., Rogers J.V., et al. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard. Toxicology 2004, 204:39-229.
24. Casillas R.P., Mitcheltree L.W., Stemler F.W. The mouse ear model of cutaneous sulfur mustard injury. Toxicol. Methods 1997, 7:97-381.
25. Casillas, R., Kam, C.M., Powers, J.C. (2000a). Serine and cysteine proteases in sulfur mustard-exposed hairless mouse skin: enzymatic: activity and inhibition profiles. J. Toxicol. Cutan. Ocul. Toxicol. 19: 137-51.
26. Casillas, R.P., Kiser, R.C. et al. (2000b). Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulation of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 20(Suppl. 1): S145-51.
27. Chiesman W.E. Diagnosis and treatment of lesions due to vesicants. Br. Med. J 1944, 12-109. ii.
28. Chilcott R.P., Jenner J., Hotchkiss S.A., Rice P. In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin. J. Appl. Toxicol 2001, 21:83-279.
29. Chilcott R.P., Jenner J., Hotchkiss S.A., Rice P. Evaluation of barrier creams against sulphur mustard. I. In vitro studies using human skin. Skin Pharmacol. Appl. Skin Physiol 2002, 15:35-225.
30. Contractor S.F. Protection against nitrogen mustard by cysteine and related substances, investigated using [3H] methyl-DI-(2-chloroethyl) amine. Biochem. Pharmacol 1963, 12(8):32-821.
31. Cowan F.M., Broomfield C.A. Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol. Toxicol 1993, 9:201-213.
32. Cowan F.M., Yourick J.J., Hurst C.G., Broomfield C.A., Smith W.J. Sulfur mustard-increased proteolysis following in vitro and in vivo exposures. Cell Biol. Toxicol 1993, 9:269-277.
33. Cowan F.M., Bongiovanni R., Broomfield C.A., Yourick J.J., Smith W.J. Sulfur mustard-increased elastase-like activity in homogenates of hairless guinea pig skin. J. Toxicol. Cutan. Ocul. Toxicol 1994, 13:221-229.
34. Dabrowska M.I., Becks L.L., Lelli J.L., Levee M.G., Hinshaw D.B. Sulfur mustard induces apoptosis and necrosis in endothelial cells. Toxicol. Appl. Pharmacol 1996, 141:568-583.
35. Dachir S., Fishbeine E., Meshulam Y., Sahar R., Amir A., Kadar T. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum. Exp. Toxicol 2002, 21:197-203.
36. Dachir S., Fishbeine E., Meshulam Y., Sahar R., Chapman S., Amir A., Kadar T. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J. Appl. Toxicol 2004, 24:107-113.
37. Dachir S., Cohen M., Fishbeine E., Gutman H., Kadar T. The advantage of using the hairless guinea pig (HGP) as a small animal model for studying healing processes following HD skin injury. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD 2006, 89. pp.
38. Dachir, S., Cohen, M., Fishbine, E., Sahar, R., Kadar, T. (2008). Beneficial effect of treatment with nonsteroidal anti-inflammatory drugs against sulfur mustard skin injury. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 150 pp.
39. Dacre J.C., Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 1996, 48:289-326.
40. Daily L.E., Clark J.W., Stolp B.N., Conner J.C. A controlled laboratory experiment to compare lesions resulting from application of mustard, lewisite, and nitrogen mustards to the skin of the forearms of humans. Pentagon Reports 1994, Naval Research Lab, Washington, DC, 34 pp.
41. Dalton, C.H., Jenner, J., Chilcott, R.P. (2004). Implications of a putative sulphur mustard skin depot in cutaneous therapeutics. Proceedings of the U.S. Army Medical Defense Bioscience Review, Aberdeen Proving Ground, MD, pp. 1-24.
42. Dalton, C.H., Hattersley, I.J., Payne, O., Jenner, J., Graham, J.S. (2008a). Collaboration toward the amelioration of sulfur mustard injury. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 260 pp.
43. Dalton, C.H., Hattersley, I.J., Payne, O., Jenner, J., Graham, J.S. (2008b). Evaluation of debriding agents against sulphur mustard (HD) injury. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 160 pp.
44. Danne M.M., Buxton K.L., Babin M.C., Sabourin C.L., Schlager J.J., Casillas R.P. Sulfur mustard-induced dermal inflammatory mediator response in porcine skin. Proceedings of the 40th Annual Meeting of the Society of Toxicology 2001, Vol. 60. Oxford University Press, San Francisco, CA, 853 pp.
45. Dannenberg A.M., Vogt R.F. Pathogenesis and treatment of skin lesions caused by sulfur mustard. Pentagon Reports 1981, Johns Hopkins University School of Hygiene and Public Health, Baltimore, MD, 26 pp.
46. Debiak M., Kehe K., Bürkle A. Role of poly(ADP-ribose) polymerase in sulfur mustard toxicity. Toxicology 2008, (June 18, Epub ahead of print) doi:10.1016/j.tox.2008.06.002.
47. Debouzy J.C., Aous S., Dabouis V., Neveux Y., Gentilhomme E. Phospholipid matrix as a target for sulfur mustard (HD): NMR study in model membrane systems. Cell Biol. Toxicol 2002, 18:397-408.
48. Di Zenzo G., Marazza G., Borradori L. Bullous pemphigoid: physiopathology, clinical features and management. Adv. Dermatol 2007, 23:257-288.
49. Dillman J.F., McGary K.L., Schlager J.J. Sulfur mustard induces the formation of keratin aggregates in human epidermal keratinocytes. Toxicol. Appl. Pharmacol 2003, 193:228-236.
50. Eldad A., Weinberg A., Breiterman S., Chaouat M., Palanker D., Ben-Bassat H. Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns. Burns 1998, 24:166-172.
51. Evison D., Brown R.F., Rice P. The treatment of sulphur mustard burns with laser debridement. J. Plast. Reconstr. Aesthet. Surg 2006, 59:1087-1093.
52. FDA Skin decontamination lotion cleared for military use. FDA Consumer 2003, 37:3.
53. Frisch S.M., Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 1994, 124:619-626.
54. Fuchs E., Keith R. Porter Lecture, 1996. Of mice and men: genetic disorders of the cytoskeleton. Mol. Biol. Cell. 1997, 8:189-203.
55. Gentilhomme E., Reano A., Pradel D., Bergier J., Schmitt D., Neveux Y. In vitro dermal intoxication by bis(chloroethyl)sulfide. Effect on secondary epidermization. Cell Biol. Toxicol 1998, 14:1-11.
56. Gerecke, D.R., Bhatt, P. et al. (2004). Sulfur mustard alters laminin 5 and gelatinase MNRA levels and increases gelatinase activity in a mouse ear vesicant model. Proceedings of the 43rd Annual Meeting of the Society of Toxicology, Baltimore, MD, 1888 pp.
57. Gerecke D.R., Bhatt P., Chang Y., et al. The matrix metalloproteinase inhibitor SM 1489 reduces MMP-9 activity after sulfur mustard exposure. in vivo. Proceedings of the 44th Annual Meeting of the Society of Toxicology, New Orleans, LA 2005, 780 pp.
58. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol 1998, 16:225-260.
59. Giancotti F.G., Tarone G. Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu. Rev. Cell. Dev. Biol. 2003, 19:173-206.
60. Gold, M.B., Bongiovanni, R., Scharf, B.A. (1993). Hypochlorite solution as a decontaminant in sulfur mustard contaminated skin defects in the euthymic hairless guinea pig. Proceedings of the U.S. Army Medical Defense Bioscience Review, Baltimore, MD, pp. 369-78.
61. Graham J.S., Bryant M.A., Braue E.H. Effect of sulfur mustard on mast cells in hairless guinea pig skin. J. Toxicol. Cutan. Ocul. Toxicol. 1994, 13:47-54.
62. 2 laser debridement. J. Toxicol. Cutan. Ocul. Toxicol 1997, 16(4):275-295.
63. Graham J.S., Martin J.L., et al. Assessment of cutaneous sulfur mustard injury in the weanling pig. Skin Res. Technol 1999, 5:56-67.
64. Graham J.S., Reid F.M., et al. A cutaneous full-thickness liquid sulfur mustard burn model in weanling swine: clinical pathology and urinary excretion of thiodiglycol. J. Appl. Toxicol 2000, 20(Suppl. 1):S161-S172.
65. Graham, J.S., Schomacker, K.T., Glatter, R.D., Briscoe, C.M., Braue, E.H., Jr., Squibb, K.S. (2002a). Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res. Technol. 8: 57-69.
66. Graham, J.S., Schomacker, K.T., Glatter, R.D., Briscoe, C.M., Braue, E.H., Jr., Squibb, K.S. (2002b). Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns 28: 719-30.
67. Graham J.S., Chilcott R.P., Rice P., Milner S.M., Hurst C.G., Maliner B.I. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J. Burns Wounds 2005, 4: e1.
68. Graham J.S., Stevenson R.S., Mitcheltree L.W., Simon M., Hamilton T.A., Deckert R.R., Lee R.B. Improved wound healing of cutaneous sulfur mustard injuries in a weanling pig model. J. Burns Wounds 2006, 5: e7.
69. Gross C.L., Innace J.K., Hovatter R.C., Meier H.L., Smith W.J. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol. Toxicol 1993, 9:259-267.
70. Guignabert C., Taysse L., Calvet J.H., Planus E., Delamanche S., Galiacy S., d'Ortho M.P. Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung Cell. Mol. Physiol 2005, 289:L67-L74.
71. Gunhan O., Kurt B., Karayilanoglu T., Kenar L., Celasun B. Morphological and immunohistochemical changes on rat skin exposed to nitrogen mustard. Mil. Med 2004, 169(1):7-10.
72. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
73. Haley B., Frenkel E. Nanoparticles for drug delivery in cancer treatment. Urol. Oncol 2008, 26:57-64.
74. Hatiboglu I. Prevention of the toxicity of nitrogen mustard (HN2) by sodium thiosulfate (ST). Proceedings of the American Association of Cancer Research 1960, Vol. 3. pp. A105.
75. Hattersley, I.J., Jenner, J., Chilcott, R.P., Graham, J.S. (2006). The skin reservoir of sulphur mustard. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 49 pp.
76. Hayden, P.J., Petrali, J.P., Hamilton, T.A., Kubilus, J., Smith, W.J., Kalusner, M. (2005). Development of a full thickness in vitro human skin equivalent (Epiderm-FT) for sulfur mustard research. Proceedings of the Society of Investigative Dermatology, St Louis, MO.
77. Hefazi M., Maleki M., Mahmoudi M., Tabatabaee A., Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int. J. Dermatol 2006, 45:1025-1031.
78. Hess J.F., FitzGerald P.G. Treatment of keratin intermediate filaments with sulfur mustard analogs. Biochem. Biophys. Res. Commun 2007, 359:616-621.
79. Higuchi K., Kajiki A., Nakamura M., Harada S., Pula P.J., Scott A.L., Dannenberg A.M. Proteases released in organ culture by acute dermal inflammatory lesions produced in vivo in rabbit skin by sulfur mustard: hydrolysis of synthetic peptide substrates for trypsin-like and chymotrypsin-like enzymes. Inflammation 1988, 12:311-334.
80. Hinshaw D.B., Lodhi I.J., Hurley L.L., Atkins K.B., Dabrowska M.I. Activation of poly [ADP-ribose] polymerase in endothelial cells and keratinocytes: role in an in vitro model of sulfur mustard-mediated vesication. Toxicol. Appl. Pharmacol 1999, 156:17-29.
81. Hobson, S.T., Braue, E.H., Lehnert, E.K. (2002a). Active topical skin protectants using combinations of reactive nanoparticles and polyoxometalates or metal salts. U.S. Patent No. 6,410,603, US Patent and Trademark Office, Washington, DC.
82. Hobson, S.T., Braue, E.H., Lehnert, E.K., Klabunde, K.J., Koper, O.P., Decker, S. (2002b). Active topical skin protectants using reactive nanoparticles. U.S. Patent No. 6,403,653, US Patent and Trademark Office, Washington, DC.
83. Hoesel L.M., Flierl M.A., et al. Ability of antioxidant liposomes to prevent acute and progressive pulmonary injury. Antioxid. Redox Signal 2008, 10:973-981.
84. Husain K., Dube S.N., Sugendran K., Singh R., Das Gupta S., Somani S.M. Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats. J. Appl. Toxicol 1996, 16:245-248.
85. Inman A.O., Monteiro-Riviere N.A., Babin M., Casillas R.P. Detection of proliferating cell nuclear antigen in the mouse ear vesicant model following exposure to bis(2-chloroethyl)sulfide. Proceedings of the 38th Annual Meeting of the Society of Toxicology 1999, Vol. 48. Oxford University Press, New Orleans, LA, 366 pp.
86. Jafari M. Dose-and time-dependent effects of sulfur mustard on antioxidant system in liver and brain of rat. Toxicology 2007, 231(1):30-39.
87. Jelenko C. Chemicals that "burn'. J. Trauma 1974, 14:66-71.
88. Joiner R.L., HarroffH.H., Keys W.B., Feder P.I. Validation of a protocol to compare the effectiveness of experimental decontaminants with component II of the M258A1 Kit or Fuller's earth standard decontaminants against percutaneous application of undiluted vesicant chemical surety material to the labor. Pentagon Report 1987, Battelle Memorial Institute, Columbus, OH, 99 pp.
89. Kam C.M., Selzler J., Schulz S.M. Enhanced serine protease activities in the sulfur mustard-exposed homogenates of hairless guinea pig skin. Int. J. Toxicol. 1997, 16:625-638.
90. Kan R.K., Pleva C.M., Hamilton T.A., Anderson D.R., Petrali J.P. Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol. Pathol 2003, 31:185-190.
91. Kehe, K., Rupec, R., Thiermann, H. (2008). Activation of NFKB and mitogen-activated protein kinase pathways in keratinocytes after sulfur mustard exposure. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 145 pp.
92. Kim Y.B., Hur G.H., Choi D.S., Shin S., Han B.G., Lee Y.S., Sok D.E. Effects of calmodulin antagonists and anesthetics on the skin lesions induced by 2-chloroethylethyl sulfide. Eur. J. Pharmacol 1996, 313:107-114.
93. Kiser R.C., Moore D.M., et al. Dose response modulation of cutaneous sulfur mustard injury. Proceedings of the 40th Annual Meeting of the Society of Toxicology 2001, Vol. 60. Oxford University Press, San Francisco, CA, 618 pp.
94. Kiser R.C., Moore D.M., et al. Mouse ear vesicant model (MEVM) evaluation of treatment combinations against topical sulfur mustard challenge. Toxicol. Sci. 2005, 84:451.
95. Koper O., Lucas E., Klabunde K.J. Development of reactive topical skin protectants against sulfur mustard and nerve agents. J. Appl. Toxicol 1999, 19(Suppl. 1):S59-S70.
96. Kulkarni A.S., Vijayaraghavan R., et al. Evaluation of analogues of DRDE-07 as prophylactic agents against the lethality and toxicity of sulfur mustard administered through percutaneous route. J. Appl. Toxicol 2006, 26:115-125.
97. Kumar O., Sugendran K., Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem. Biol. Interact 2001, 134:1-12.
98. Lefkowitz L.J., Smith W.J. Sulfur mustard-induced arachidonic acid release is mediated by phospholipase D in human keratinocytes. Biochem. Biophys. Res. Commun 2002, 295:1062-1067.
99. Li W.H., Lee Y.M., et al. Transient receptor potential vanilloid-1 mediates heat-shock-induced matrix metalloproteinase-1 expression in human epidermal keratinocytes. J. Invest. Dermatol 2007, 127:2328-2335.
100. Lindsay C.D., Hambrook J.L. Diisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum. Exp. Toxicol 1998, 17:606-612.
101. Lindsay C.D., Rice P. Assessment of the biochemical effects of percutaneous exposure of sulphur mustard in an in vitro human skin system. Hum. Exp. Toxicol 1996, 15:237-244.
102. Lindsay C.D., Gentilhomme E., Mathieu J.D. The use of doxycycline as a protectant against sulphur mustard in HaCaT cells. J. Appl. Toxicol 2007, 28:665-673.
103. Liu D.K., Wannemacher R.W., Snider T.H., Hayes T.L. Efficacy of the topical skin protectant in advanced development. J. Appl. Toxicol 1999, 19(Suppl. 1):S40-S45.
104. Logan T.P., Graham J.S., Martin J.L., Zallnick J.E., Jakubowski E.M., Braue E.H. Detection and measurement of sulfur mustard offgassing from the weanling pig following exposure to saturated sulfur mustard vapor. J. Appl. Toxicol 2000, 20(Suppl. 1):S199-S204.
105. Lyle R.E., Hamil H.F., McGovern E.P., Trujillo D.A. Decontamination of casualties from battlefield under CW and BW attack. Pentagon Reports 1984, Southwest Research Institute, San Antonio, TX, 85 pp.
106. Lyle R.E., McMahon W.A., Trujillo D.A. Decontamination systems for skin. Pentagon Reports 1986, Southwest Research Institute, San Antonio, TX, 52 pp.
107. Margulis M., Chaouat M., Ben-Bassat H., Eldad A., Icekson M., Breiterman S., Rami Neuman R. Comparison of topical iodine and silver sulfadiazine as therapies against sulfur mustard burns in a pig model. Wound Repair Regen. 2007, 15(6):916-921.
108. Marlow, D.D., Mershon, M., Mitcheltree, L.W., Petrali, J.P., Jaax, G.P. (1990a). Evaluation of euthymic hairless guinea pigs [crl:IAF(HA)BR] as an animal model for vesicant injury. J. Toxicol. Cutan. Ocul. Toxicol. 9: 179-92.
109. Marlow, D.D., Mershon, M.M., Mitcheltree, L.W., Petrali, J.P., Jaax, G.P. (1990b). Sulfur mustard-induced skin injury in hairless guinea pigs. J. Toxicol. Cutan. Ocul. Toxicol. 9: 179-92.
110. {thorn} depletion in the mechanism of sulfur mustard-induced metabolic injury. J. Toxicol. Cutan. Ocul. Toxicol 2008, 27:41-53.
111. Matijasevic Z., Volkert M.R. Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide. DNA Repair 2007, 6(6):733-741.
112. McKinley, M.D., McKinley, F.R., McGown, E.L. (1982). Thiosulfate as an antidote to mustard poisoning. A review of the literature. Pentagon Reports. Letterman Army Institute of Research, Presidio of San Francisco, CA, 25 pp.
113. McNamara B.P. Medical aspects of chemical warfare. US Army Chemical Research and Development Laboratories 1960, Army Chemical Center, Edgewood Arsenal, MD, 7-28.
114. Mershon M.M., Mitcheltree L.W., Petrali J.P., Braue E.H., Wade J.V. Hairless guinea pig bioassay model for vesicant vapor exposures. Fundam. Appl. Toxicol 1990, 15:622-630.
115. Millard C.B., Bongiovanni R., Broomfield C.A. Cutaneous exposure to bis-(2-chloroethyl)sulfide results in neutrophil infiltration and increased solubility of 180,000 Mr subepidermal collagens. Biochem. Pharmacol 1997, 53:1405-1412.
116. Minsavage G.D., Dillman Iii J.F. Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor-kappa B (NF-kB) responses and cell death are altered by caffeic acid phenethyl ester (CAPE): a potential role for antioxidant/electrophilic response element (ARE/EpRE) signaling. J. Pharmacol. Exp. Ther 2007, 321:202-212.
117. Mohan R., Chintala S.K., et al. Matrix metalloproteinase gelatinase B (MMP-9) coordinates and effects epithelial regeneration. J. Biol. Chem. 2002, 277:2065-2072.
118. Mol M.A. Implications of protein alkylation and proteolysis on vesication caused by sulfur mustard. TNO Prins Maurits Laboratorium 1999, Rijswijk, Netherlands, Pentagon Reports62 pp.
119. Mol, M.A.E., Van den Berg, R.M. (2006). Inhibitors of matrix metalloproteases and caspases are potential countermeasures against sulfur mustard exposure of skin. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 135 pp.
120. Monteiro-Riviere N.A., Inman A.O. Histochemical localization of three basement membrane epitopes with sulfur mustard induced toxicity in porcine skin. Proceedings of the 32nd Annual Meeting of the Society of Toxicology 1993, Vol. 13. 126 pp.
121. Monteiro-Riviere N.A., Inman A.O. Indirect immunohistochemistry and immunoelectron microscopy distribution of eight epidermal-dermal junction epitopes in the pig and in isolated perfused skin treated with bis (2-chloroethyl) sulfide. Toxicol. Pathol 1995, 23:313-325.
122. Monteiro-Riviere N.A., Inman A.O. Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin. Microsc. Res. Tech 1997, 37:229-241.
123. Monteiro-Riviere N.A., King J.R., Riviere J.E. Cutaneous toxicity of mustard and lewisite on the isolated perfused porcine skin flap. Pentagon Reports. North Carolina State University at Raleigh 1990, School of Veterinary Medicine, Raleigh, NC, 144 pp.
124. Monteiro-Riviere N.A., Inman A.O., Snider T.H., Blank J.A., Hobson D.W. Comparison of an in vitro skin model to normal human skin for dermatological research. Microsc. Res. Tech 1997, 37:172-179.
125. Nelson, P., Sawyer, T.W. (2006). Therapeutic effects of hypothermia on lewisite toxicity. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 154 pp.
126. Nicholson, J.D., Cowan, F.M., Bergerson, R.J., Brimfield, A.A., Baskin, S.I., Smith, W.J. (2004). Doxycycline and HBED iron chelator decrease IL-8 production by sulfur mustard exposed to human keratinocytes. Proceedings of the U.S. Army Medical Defenase Bioscience Review, Aberdeen Proving Ground, MD, 224 pp.
127. Noort D., Benschop H.P., Black R.M. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol. Appl. Pharmacol 2002, 184:116-126.
128. Omaye S.T., Elsayed N.M., Klain G.J., Korte D.W. Metabolic changes in the mouse kidney after subcutaneous injection of butyl 2-chloroethyl sulfide. J. Toxicol. Environ. Health 1991, 33:19-27.
129. O'Shea J.J., Murray P.J. Cytokine signaling modules in inflammatory responses. Immunity 2008, 28:477-487.
130. Owens G., Hatiboglu I. Clinical evaluation of sodium thiosulfate as a systemic neutralizer of nitrogen mustard: Report of 12 patients. Ann. Surg 1961, 154:895-897.
131. Pant S.C., Vijayaraghavan R., Kannan G.M., Ganesan K. Sulphur mustard induced oxidative stress and its prevention by sodium 2,3-dimercapto propane sulphonic acid (DMPS) in mice. Biomed. Environ. Sci. 2000, 13:225-232.
132. Papirmeister B., Gross C.L., Meier H.L., Petrali J.P., Johnson J.B. Molecular basis for mustard-induced vesication. Fundam. Appl. Toxicol 1985, 5:S134-S149.
133. Papirmeister, B., Feister, A.J., Robinson, S.I., Ford, R.D. (1991a). Histopathology of sulfur mustard exposure. In Medical Defense Against Mustard Gas, pp. 174-91. CRC Press, Boca Raton, FL.
134. Papirmeister, B., Feister, A.J., Robinson, S.I., Ford, R.D. (1991b). Medical Defense against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. CRC Press, Boca Raton, FL.
135. Papirmeister B., Feister A.J., Robinson S.I., Ford R.D. description of lesions and resulting incapacitation. Medical Defense Against Mustard Gas: Toxic Mechanisms and Pharmacological Implications 1991, CRC Press, Boca Raton, FL, The sulfur mustard injurypp. 21-3.
136. Parks W.C., Wilson C.L., Lopez-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. Immunol 2004, 4:617-629.
137. Paromov, V., Kumari, S., Brannon, M., Myenyi, C., Stone, W.L. (2008). The protective effect of antioxidant liposomes in a human epidermal model exposed to a vesicating agent. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 25 pp.
138. Petrali J.P., Oglesby S.B., Hamilton T.A., Mills K.R. Comparative morphology of sulfur mustard effects in the hairless guinea pig and a human skin equivalent. J. Submicrosc. Cytol. Pathol 1993, 25:113-118.
139. Pillay E. causes, presentation and complications. Br. J. Nurs 2008, 17:292-296. Epidermolysis bullosa. Part 1.
140. Powers J.C., Kam C.M., Ricketts K.M., Casillas R.P. Cutaneous protease activity in the mouse ear vesicant model. J. Appl. Toxicol 2000, 20(Suppl. 1):S177-S182.
141. Prasad, G.K., Mahato, T.H., Singh, B., Ganesan, K., Pandey, P., Sekhar, K. (2007a). Detoxification reactions of sulphur mustard on the surface of zinc oxide nanosized rods. J. Hazard. Mater. 149: 460-4.
142. Prasad, G.K., Mahato, T.H., Singh, B., Pandey, P., Rao, A.N., Ganesan, K., Vijayraghavan, R. (2007b). Decontamination of sulfur mustard on manganese oxide nanostructures. AIChE J. 53(6): 1562-7.
143. Pulkkinen L., Uitto J. Hemidesmosomal variants of epidermolysis bullosa. Mutations in the alpha6beta4 integrin and the 180-kD bullous pemphigoid antigen/type XVII collagen genes. Exp. Dermatol 1998, 7:46-64.
144. Ray R., Majerus B.J., Munavalli G.S., Petrali J.P. Sulfur mustard-induced increase in intracellular calcium: a mechanism of mustard toxicity. Proceedings of the U.S. Army Medical Bioscience Review 1993, 267-276.
145. Ray R., Legere R.H., Majerus B.J., Petrali J.P. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol. Appl. Pharmacol 1995, 131:44-52.
146. Rebholz B., Kehe K., Ruzicka T., Rupec R.A. Role of NF-kappaB/RelA and MAPK pathways in keratinocytes in response to sulfur mustard. J. Invest. Dermatol 2008, 128:1626-1632.
147. Reid F.M., Niemuth N.A., Shumaker S.M., Waugh J.A., Graham J.S. Biomechanical monitoring of cutaneous sulfur mustard-induced lesions in the weanling pig model for depth of injury. Skin Res. Technol 2007, 13(2):217-225.
148. Reid, F.M., Kiser, R.C., Hart, W.E., McGuinness, E.E., Mann, J., Graham, J.S. (2008a). Steroid efficacy applied to two depths of dermal injuries induced by sulfur mustard or liquid bromine. Proceedings of the U.S. Army Medical Defense Bioscience Review, Hunt Valley, MD, 168 pp.
149. Reid F.M., Kiser R.C., Hart W.E., McGuinness E.E., Mann J., Graham J.S. A sulfur mustard and thermal superficial dermal injury pig model. Proceedings of the U.S. Army Medical Defense Bioscience Review 2008, 169. pp.
150. Requena L., Requena C., Sanchez M., Jaqueti G., Aguilar A., Sanchez-Yus E., Hernandez-Moro B. Chemical warfare. Cutaneous lesions from mustard gas. J. Am. Acad. Dermatol 1988, 19:529-536.
151. Rice P. Sulphur mustard injuries of the skin. Pathophysiology and management. Toxicol. Rev. 2003, 22:111-118.
152. Rice P., Brown R.F., Lam D.G., Chilcott R.P., Bennett N.J. Dermabrasion -a novel concept in the surgical management of sulphur mustard injuries. Burns 2000, 26:34-40.
153. Ricketts K.M., Santai C.T., France J.A., Graziosi A.M., Doyel T.D., Gazaway M.Y., Casillas R.P. Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J. Appl. Toxicol 2000, 20(Suppl. 1):S73-S76.
154. Rikimaru T., Nakamura M., et al. Mediators, initiating the inflammatory response, released in organ culture by full-thickness human skin explants exposed to the irritant, sulfur mustard. J. Invest. Dermatol 1991, 96:888-897.
155. Risk D., Verpy D., Conley J.D., Jacobson T., Sawyer T.W. Volatile anesthetics give a false-positive reading in chemical agent monitors in the "H' mode. Mil. Med 2001, 166:708-710.
156. Riviere J.E., Brooks J.D., Williams P.L., Monteiro-Riviere N.A. Toxicokinetics of topical sulfur mustard penetration, disposition, and vascular toxicity in isolated perfused porcine skin. Toxicol. Appl. Pharmacol 1995, 135:25-34.
157. Riviere J.E., Monteiro-Riviere N.A., Inman A.O. The effect of altered media flow and glucose concentration on sulfur mustard toxicity in the isolated perfused porcine skin flap. In Vitro Toxicol. 1997, 10:169-181.
158. Rosenthal D.S., Simbulan-Rosenthal C.M., et al. PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard. J. Invest. Dermatol 2001, 117:1566-1573.
159. Rosenthal D.S., Velena A., et al. Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J. Biol. Chem. 2003, 278:8531-8540.
160. Rosenthal, D.S., Ray, R., Benton, B., Velarde, A., Chou, F-P., Anderson, D.R., Smith, W.J., Simbulan-Rosenthal, C.M. (2004). Characterization and modulation of proteins involved in sulfur mustard vesication. Proceedings of the U.S. Army Medical Defense Bioscience Review, Aberdeen Proving Ground, MD, pp. 1-10.
161. RuffA.L., Dillman J.F. Signaling molecules in sulfur mustard-induced cutaneous injury. Eplasty 2007, 8: e2.
162. Sabourin C.L., Petrali J.P., Casillas R.P. Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J. Biochem. Mol. Toxicol 2000, 14:291-302.
163. Sabourin C.L., Danne M.M., Buxton K.L., Casillas R.P., Schlager J.J. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J. Biochem. Mol. Toxicol 2002, 16:263-272.
164. Sabourin C.L.K., Danne M.M., et al. Modulation of sulfur mustard-induced inflammation and gene expression by Olvanil in the hairless mouse vesicant model. J. Toxicol. Cutan. Ocular Toxicol. 2003, 22(3):125-136.
165. Sabourin C.L.K., Rogers J.V., et al. Alterations of gene expression in sulfur mustard-exposed skin topically treated with vanilloids. J. Toxicol. Cutan. Ocular Toxicol. 2004, 23(4):321-328.
166. Sawyer T.W., Hamilton M.G. Effect of intracellular calcium modulation on sulfur mustard cytotoxicity in cultured human neonatal keratinocytes. Toxicol. Vitro 2000, 14:149-157.
167. Sawyer T.W., Nelson P. Hypothermia as an adjunct therapy to vesicant-induced skin injury. Eplasty 2008, 8: e25.
168. Sawyer T.W., Risk D. Effect of lowered temperature on the toxicity of sulphur mustard in vitro and. in vivo. Toxicology 1999, 134:27-37.
169. Sawyer T.W., Nelson P., Hill I., Conley J.D., Blohm K., Davidson C., Sawyer T.W. Therapeutic effects of cooling swine skin exposed to sulfur mustard. Mil. Med 2002, 167:939-943.
170. Sawyer, T.W., Parker, D., Thomas, N., Weiss, M.T., Bide, R.W. (1991a). Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in vivo and in vitro. Toxicology 67: 267-77.
171. Sawyer, T.W., Weiss, M.T., Boulet, C.A., Hansen, A.S. (1991b). Toxicity of organophosphate nerve agents and related phosphonylated oximes compared to their anticholinesterase activity in neuron cultures. Fundam. Appl. Toxicol. 17: 208-14.
172. Schultz, G.S., Mol, M.A.E., Galardy, R.E., Friel, G.E. (2004). Protease inhibitor treatment of sulfur mustard injuries in cultured human skin. Proceedings of the U.S. Army Medical Defense Bioscience Review, Aberdeen Proving Ground, MD.
173. Shakarjian M.P., Bhatt P., et al. Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J. Appl. Toxicol 2006, 26:239-246.
174. Shall S., de Murcia G. Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?. Mutat. Res. 2000, 460:1-15.
175. Sidell F.R., Urbanetti J.S., Smith W.J., Hurst C.G. Textbook of Military Medicine, Part I -Medical Aspects of Chemical and Biological Warfare, Chapter 7. Office of the Surgeon General at TMM Publications, Borden Institute, Walter Reed Army Medical Center 1997, 197-228. Dept of the Army, Washington, DC, Vesicants. R. Zaitchuk, R.F. Bellamy (Eds.).
176. Simbulan-Rosenthal C.M., Ray R., et al. Calmodulin mediates sulfur mustard toxicity in human keratinocytes. Toxicology 2006, 227:21-35.
177. Simpson R., Lindsay C.D. Effect of sulphur mustard on human skin cell lines with differential agent sensitivity. J. Appl. Toxicol 2005, 25:115-128.
178. Singh B., Saxena A., Nigam A.K., Ganesan K., Pandey P. Impregnated silica nanoparticles for the reactive removal of sulphur mustard from solutions. J. Hazard Mater. (April 24, Epub ahead of print) doi:10.1016/j.jhazmat. 2008, 2008.04.076.
179. Smith C.N., Lindsay C.D., Upshall D.G. Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulphur mustard on cultured SVK-14 human keratinocytes in vitro. Hum. Exp. Toxicol 1997, 16:247-253.
180. Smith K.J., Graham J.S., Moeller R.B., Okerberg C.V., Skelton H., Hurst C.G. Histopathologic features seen in sulfur mustard induced cutaneous lesions in hairless guinea pigs. J. Cutan. Pathol 1995, 22:260-268.
181. Smith K.J., Skelton H.G., Hobson D.W., Reid F.M., Blank J.A., Hurst C.G. Cutaneous histopathologic features in weanling pigs after exposure to three different doses of liquid sulfur mustard. Am. J. Dermatopathol 1996, 18:515-520.
182. Smith K.J., Casillas R., Graham J., Skelton H.G., Stemler F., Hackley B.E. Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J. Dermatol. Sci. 1997, 14:126-135.
183. Smith K.J., Graham J.S., Hamilton T.A., Skelton H.G., Petrali J.P., Hurst C.G. Immunohistochemical studies of basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs. J. Dermatol. Sci. 1997, 15:173-182.
184. Smith K.J., Smith W.J., et al. Histopathologic and immunohistochemical features in human skin after exposure to nitrogen and sulfur mustard. Am. J. Dermatopathol 1998, 20:22-28.
185. Smith W.J., Cowan F.M., Broomfield C.A. Increased proteolytic activity in human epithelial cells following exposure to sulfur mustard. FASEB J 1991, 5:A828.
186. Sollmann T. Dichlorethylsulphide ("mustard gas') I. The influence of solvents, absorbents and chemical antidotes on the severity of the human skin lesions. J. Pharmacol. Exp. Ther 1919, 12:303-318.
187. 2 and ferrihydrite. J. Chem. Tech. Biotech 2005, 80(7):754-758.
188. Szallasi A., Blumberg P.M. Vanilloid (capsaicin) receptors and mechanisms. Pharmacol. Rev. 1999, 51:159-212.
189. Szolcsanyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 2004, 38:377-384.
190. Tanaka F., Dannenberg A.M., et al. Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard. Inflammation 1997, 21:251-267.
191. Taysse L., Daulon S., Delamanche S., Bellier B., Breton P. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine. Hum. Exp. Toxicol 2007, 26(2):135-141.
192. Uitto J., Richard G., McGrath J.A. Diseases of epidermal keratins and their linker proteins. Exp. Cell Res. 2007, 313:1995-2009.
193. USAMRICD (2007). Medical Management of Chemical Casualties Handbook. USAMRICD, Aberdeen Proving Ground.
194. Van Hooidonk C., Ceulen B.I., Bock J., van Genderen J. CW agents and the skin. Penetration and decontamination. Proceedings of the International Symposium on Protection Against Chemical Warfare Agents 1983, Sweden, National Defence Research Institute, Umea, Stockholm, Swedenpp. 153-60.
195. Vogt R.F., Dannenberg A.M., Schofield B.H., Hynes N.A., Papirmeister B. Pathogenesis of skin lesions caused by sulfur mustard. Fundam. Appl. Toxicol 1984, 4:S71-S83.
196. Vojvodic V., Milosavljevic Z., Boskovic B., Bojanic N. The protective effect of different drugs in rats poisoned by sulfur and nitrogen mustards. Fundam. Appl. Toxicol 1985, 5:S160-S168.
197. Walker I.G. Intrastrand bifunctional alkylation of DNA in mammalian cells treated with mustard gas. Can. J. Biochem 1971, 49:332-336.
198. Walter J.F., DeQuoy P.R. The hairless mouse as a model for evaluating sunscreens. Prevention of ultraviolet B inhibition of epidermal DNA synthesis. Arch. Dermatol 1980, 116:419-421.
199. Werrlein R.J., Madren-Whalley J.S. Effects of sulfur mustard on the basal cell adhesion complex. J. Appl. Toxicol 2000, 20(Suppl. 1):S115-S123.
200. Wheeler L.A., Aswad A., Connor M.J., Lowe N. Depletion of cutaneous glutathione and the induction of inflammation by 8-methoxypsoralan plus UVA radiation. J. Invest. Dermatol 1986, 87:658-688.
201. Woessner J.F., Dannenberg A.M., et al. Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard. J. Invest. Dermatol 1990, 95:717-726.
202. Wormser U. Toxicology of mustard gas. Trends Pharmacol. Sci. 1991, 12:164-167.
203. Wormser U., Brodsky B., Sintov A. Skin toxicokinetics of mustard gas in the guinea pig: effect of hypochlorite and safety aspects. Arch. Toxicol 2002, 76:517-522.
204. Wormser U., Brodsky B., Proscura E., Foley J.F., Jones T., Nyska A. Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; effect of topical iodine. Arch. Toxicol 2005, 79:660-670.
205. Yancey K.B. The pathophysiology of autoimmune blistering diseases. J. Clin. Invest 2005, 115:825-828.
206. Yourick J.J., Clark C.R., Mitcheltree L.W. Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard. Fundam. Appl. Toxicol 1991, 17:533-542.
207. Yourick J.J., Dawson J.S., Mitcheltree L.W. Sulfur mustard-induced microvesication in hairless guinea pigs: effect of short-term niacinamide administration. Toxicol. Appl. Pharmacol 1992, 117:104-109.
208. Yourick J.J., Dawson J.S., Benton C.D., Craig M.E., Mitcheltree L.W. Pathogenesis of 2,20-dichlorodiethyl sulfide in hairless guinea pigs. Toxicology 1993, 84:185-197.
209. Yourick J.J., Dawson J.S., Mitcheltree L.W. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J. Appl. Toxicol 1995, 15:133-138.
210. Zhang Z., Monteiro-Riviere N.A. Comparison of integrins in human skin, pig skin, and perfused skin: an in vitro skin toxicology model. J. Appl. Toxicol 1997, 17:247-253.
211. Zhang Z., Peters B.P., Monteiro-Riviere N.A. Sulfur mustard alkylates laminin by cross linking. Proceedings of the 33rd Annual Meeting of the Society of Toxicology 1994, Vol. 14. Academic Press, Dallas, TX, 1694 pp.
212. Zhang, Z., Peters, B.P., Monteiro-Riviere, N.A. (1995a). Assessment of sulfur mustard interaction with basement membrane components. Cell Biol. Toxicol. 11: 89-101.
213. Zhang, Z., Riviere, J.E., Monteiro-Riviere, N.A. (1995b). Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin. Chem. Biol. Interact. 96: 249-62.